Breaking News Instant updates and real-time market news.

T

AT&T

$30.58

-1.29 (-4.05%)

, VZ

Verizon

$54.36

-2.47 (-4.35%)

06:27
06/03/19
06/03
06:27
06/03/19
06:27

AT&T's streaming plans hit snag over price of HBO subscription, NY Times reports

At&T (T) is on its way toward creating a streaming service with enough content to compete with Verizon (VZ), T-Mobile (TMUS), Netflix (NFLX) and Disney's (DIS) Hulu after its $80B deal with Time Warner, but the plans have hit a snag over how much it should cost for subscribers, the New York Times' Edmund Lee reports, citing three people familiar with the strategy. The issue is HBO, which has 7M online customers and costs $15 a month, a price that is higher than the amounts charged by any future streaming competitors and that is practically locked in due to contracts with distributors like Comcast (CMCSA, CMCSK) and Dish (DISH). Reference Link

T

AT&T

$30.58

-1.29 (-4.05%)

VZ

Verizon

$54.36

-2.47 (-4.35%)

TMUS

T-Mobile

$73.46

-2.57 (-3.38%)

NFLX

Netflix

$343.27

-8.35 (-2.37%)

DIS

Disney

$132.06

-0.15 (-0.11%)

CMCSA

Comcast

$41.00

-0.74 (-1.77%)

CMCSK

Comcast

$0.00

(0.00%)

DISH

Dish

$36.11

1.35 (3.88%)

  • 03

    Jun

  • 03

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 06

    Jun

  • 12

    Jun

  • 13

    Jun

  • 25

    Jun

  • 26

    Jun

  • 27

    Jun

  • 24

    Jul

  • 01

    Aug

T AT&T
$30.58

-1.29 (-4.05%)

05/31/19
JPMS
05/31/19
NO CHANGE
JPMS
Verizon, AT&T selloffs present buying opportunities, says JPMorgan
JPMorgan analyst Philip Cusick believes Amazon.com (AMZN) is unlikely to enter the wireless market via an acquisition of Boost Mobile, as reported last night by Reuters. As a result, he believes the selloffs today in shares of Verizon Communications (VZ) and AT&T (T) present buying opportunities.
05/31/19
OPCO
05/31/19
NO CHANGE
OPCO
Outperform
AT&T, Verizon may trade down on Amazon/Boost Mobile news, says Oppenheimer
Following reports that Amazon (AMZN) is interested in buying Boost Mobile from T-Mobile (TMUS) and Sprint (S), Oppenheimer analyst Timothy Horan tells investors in a research note that he believes a deal would be "highly disruptive" to the industry, but would enable the merger approval for the Sprint-T-Mobile deal. The analyst sees Outperform-rated AT&T (T) and Perform-rated Verizon (VZ) trading down on the news, and Sprint trading higher.
05/15/19
JPMS
05/15/19
NO CHANGE
Target $67
JPMS
Neutral
Amdocs price target lowered to $67 from $70 at JPMorgan
JPMorgan analyst Jackson Ader lowered his price target for Amdocs (DOX) to $67 from $70 saying that while the company's fiscal Q2 results were better than expected, the commentary on AT&T (T) is the main takeaway. AT&T revenue is off to a worse start for the first half than the company had expected as the focus on cost cutting and debt reduction within AT&T continues, Ader tells investors in a research note. The analyst does not see "this AT&T headwind going anywhere" and he keeps a Neutral rating on Amdocs.
05/09/19
SBSH
05/09/19
UPGRADE
SBSH
Neutral
CenturyLink upgraded to Neutral on cash flow, cost cutting at Citi
As previously reported, Citi analyst Michael Rollins upgraded CenturyLink (CTL) to Neutral from Sell. While he said the company reported "another mixed quarter" and he thinks the pace of revenue decline should continue to depress the multiple, the company's "aggressive" cost cutting, cash flow and dividend yield should provide downside support, Rollins tells investors. He remains cautious on whether CenturyLink can create value by separating its consumer business, he added. Rollins recommends that investors seeking dividends in Telco buy AT&T (T) and Verizon (VZ) instead.
VZ Verizon
$54.36

-2.47 (-4.35%)

05/30/19
05/30/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Verizon (VZ) downgraded to Neutral from Buy at UBS with analyst John Hodulik saying with the valuation back in-line with historical levels and more difficult comps ahead, Verizon's risk/reward is more balanced at current share levels. 2. Canada Goose (GOOS) downgraded to Neutral from Buy at BofA/Merrill with analyst Robert Ohmes saying the Direct-to-Consumer, or DTC, slowdown indicates saturation risk and warrants a lower multiple. 3. ViaSat (VSAT) downgraded to Market Perform from Outperform at Raymond James with analyst Rick Prentiss saying shares are up 55% year-to-date, reflecting good news, and expects an increase in R&D and capex from VS-3 satellite builds and deployments, expanding LatAm operations, and acquiring STCs. 4. Teva (TEVA) double downgraded to Underperform from Buy at BofA/Merrill with analyst Jason Gerberry saying Teva's financial downside to ongoing opioid litigation is difficult to gauge and the highly fragmented nature of the lawsuits makes a global settlement unlikely. 5. Toll Brothers (TOL) downgraded to Market Perform from Outperform at Raymond James with analyst Buck Horne saying he is "concerned" that shares will be range-bound near-term due to reduced estimates, a lack of upcoming catalysts, and lingering West Coast issues. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/30/19
UBSW
05/30/19
DOWNGRADE
Target $59
UBSW
Neutral
Verizon downgraded to Neutral from Buy at UBS
UBS analyst John Hodulik downgraded Verizon Communications to Neutral from Buy with an unchanged price target of $59. The stock closed yesterday down 55c to $58.18. With the valuation back in-line with historical levels and more difficult comps ahead, Verizon's risk/reward is more balanced at current share levels, Hodulik tells investors in a research note. The analyst, however, continues to believe the company is well positioned as a defensive investment with low-single-digit core growth and a sustainable yield. He also expects wireless fundamentals to remain "healthy."
TMUS T-Mobile
$73.46

-2.57 (-3.38%)

05/22/19
BOFA
05/22/19
UPGRADE
Target $11.4
BOFA
Buy
Ericsson upgraded to Buy on 5G leadership, Huawei pressures at BofA/Merrill
As previously reported, BofA Merrill Lynch analyst Tal Liani upgraded Ericsson to Buy from Neutral, citing its 5G leadership and potential for longer-term share gains as well as the U.S. pressures on Huawei, which he thinks may add to Ericsson share gains. Additionally, the T-Mobile (TMUS) and Sprint (S) merger, if approved, may help accelerate the 5G timeline, Liani tells investors. The analyst, who added that he had a bullish visit to Ericsson's headquarters last Friday, raised his price target on the ADRs to $11.40 from $10.40.
05/21/19
COWN
05/21/19
NO CHANGE
COWN
State AGs may challenge Sprint, T-Mobile deal even if DOJ approves, says Cowen
Cowen analyst Paul Gallant said he believes that the Department of Justice is likely to approve T-Mobile's (TMUS) deal to buy Sprint (S) despite the Bloomberg report claiming that the DOJ is leaning against signing off on the agreement, with the main reason for his view being the belief that the White House really cares about beating China in 5G. However, he still sees significant risk at the state AG level, noting that Maryland AG Brian Frosch was quoted by Bloomberg as saying that "consumers are going to suffer in terms of price, in terms of quality, in terms of opportunities." Even if the DOJ approves the deal, state AGs have the authority to challenge and they might, Gallant tells investors.
NFLX Netflix
$343.27

-8.35 (-2.37%)

05/07/19
BMOC
05/07/19
NO CHANGE
Target $170
BMOC
Outperform
Disney price target raised to $170 from $140 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Disney (DIS) to $170 and kept his Outperform rating ahead of its Q2 results, saying he expects an "upbeat quarter" and positive commentary around June quarter's main events of Endgame box office and the first Edge of Galaxy opening. The analyst also believes that the company will join Netflix (NFLX) and Amazon (AMZN) at the helm of global streaming while noting that its Star Wars themed lands its theme parks and the launch of Disney+ will materialize as catalysts for this year.
04/26/19
IMPC
04/26/19
NO CHANGE
Target $458
IMPC
Outperform
Imperial trims Netflix target to $458 after senior notes issuance
Imperial Capital analyst David Miller lowered his price target for Netflix to $458 from $463 saying the company this week tapped the high yield market for the ninth time in the last six years by issuing $2.24B of senior notes in two series. The proceeds will likely go almost entirely towards international content acquisition, mostly on the self-produced side, "which obviously drives subscriber growth," Miller tells investors in a research note. He believes Netflix has a history of using the bond market effectively and keeps an Outperform rating on the shares.
04/30/19
JPMS
04/30/19
NO CHANGE
Target $1310
JPMS
Overweight
Alphabet sub-20% sales growth to bring share pressure, says JPMorgan
JPMorgan analyst Doug Anmuth expects Alphabet (GOOGL) shares to be under pressure in the near-term given the company's sub-20% revenue growth in Q1 and downward earnings revisions. The exact drivers of Alphabet's slowing sales are unclear, and frustration around the company's lack of transparency will only increase, Anmuth tells investors in a post-earnings research note. The analyst, however, points out that Alphabet has maintained 20%-plus growth for a very long time, off a large base. He maintains an Overweight rating on the stock with a $1,310 price target but prefers shares of Facebook (FB), Amazon.com (AMZN) and Netflix (NFLX) to Alphabet.
05/13/19
PIPR
05/13/19
NO CHANGE
Target $440
PIPR
Overweight
Piper survey shows limited risk to Netflix from Disney streaming service
Piper Jaffray asked 1,536 U.S. Netflix (NFLX) subscribers if they would subscribe to both Disney's (DIS) new streaming service and Netflix, only Netflix or only Disney+, analyst Michael Olson tells investors in a research note. Piper indicated that the Disney+ price point is $7 per month, which it believes will prove to be only an introductory price. The results show that 73% of U.S. Netflix subscribers do not expect to subscribe to Disney+, 20% expect to subscribe to both services, and only 7% indicated that they will cancel Netflix and subscribe to Disney+, Olson tells investors in a research note. The results suggest Netflix's risk of share loss is limited to a small percentage of its base, concludes the analyst. As such, he expects Netflix to continue to "capture a significant portion of the tidal wave of traditional content dollars that are migrating to streaming." Olson maintains an Overweight rating on Netflix shares with a $440 price target. The stock closed Friday down $1.71 to $361.04.
DIS Disney
$132.06

-0.15 (-0.11%)

05/15/19
MSCO
05/15/19
NO CHANGE
MSCO
Overweight
Disney will have 'high class problem' if it has to pay more for Hulu, says Morgan Stanley
After Disney (DIS) and Comcast (CMCSA) announced a new agreement regarding their Hulu joint venture, Morgan Stanley analyst Benjamin Swinburne said the new pact is indicative of the priorities of both companies. Operational control of Hulu give Disney a chance to bundle the service with Disney Plus and/or ESPN Plus, allows for international expansion and likely creates some cost synergies, said Swinburne, who added that Disney will have "a high class problem" if it turns out if Hulu is appraised at a higher value when it comes time to buy out Comcast. For Comcast, the new deal gives it downside protection and content flexibility as it builds out its own streaming plans, the analyst added. He keeps Overweight ratings on both Disney and Comcast, concluding that the deal between the media giants will accelerate the transition from legacy TV to streaming.
05/09/19
FBCO
05/09/19
NO CHANGE
Target $130
FBCO
Neutral
Disney price target raised to $130 from $114 at Credit Suisse
Credit Suisse analyst Douglas Mitchelson raised his price target for Disney to $130 from $114 as he believes adding Fox is accretive to long-term value, increasing terminal growth to 3% from 2%, and rolling his target forward one year to 2019. The analyst reiterates a Neutral rating on the shares.
05/09/19
JPMS
05/09/19
NO CHANGE
Target $150
JPMS
Overweight
Disney continues to deliver in every segment, says JPMorgan
JPMorgan analyst Alexia Quadrani reiterates an Overweight rating on Disney with a $150 price target following last night's "strong" quarter. The company's upside to revenue and profits was driven by the core business, which has largely been overshadowed in recent months in anticipation of the Disney+ unveiling, Quadrani tells investors in a post-earnings research note. She believes Disney continues to deliver in every segment, with notable upside this quarter at the Parks. However, the stock may remain range bound near term following the recent run as near-term estimates fluctuate given the lack of clarity around Fox's financial contribution, says the analyst. Nonetheless, she believes Disney shares have the potential to further re-rate in the longer term.
CMCSA Comcast
$41.00

-0.74 (-1.77%)

05/30/19
GUGG
05/30/19
UPGRADE
Target $52
GUGG
Buy
Comcast upgraded to Buy on successful connectivity pivot at Guggenheim
As previously reported, Guggenheim analyst Mike McCormack upgraded Comcast to Buy from Neutral, contending that the company's successful pivot from primarily a video distributor to a connectivity company "has been fairly smooth." The results in Q1 showed that multiple-system operators and cable operators are outgaining telecom rivals in the broadband space meaningfully, said McCormack, who added that he expects continued broadband gains. Additionally, NBCU keeps operating at "a very high level" and the Wireless business is showing steady gains, according to McCormack, who raised his price target on Comcast shares to $52 from $39.
05/30/19
05/30/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Citi (C) upgraded to Buy from Neutral at Goldman Sachs with analyst Richard Ramsden saying he sees a "realistic path" to a 13% return on tangible common equity in 2020 for Citi, or 100 basis points ahead of market expectations, which he notes is not contingent on either higher interest rates or strengthening global growth trends. 2. Comcast (CMCSA) upgraded to Buy from Neutral at Guggenheim with analyst Mike McCormack saying the company's successful pivot from primarily a video distributor to a connectivity company "has been fairly smooth." 3. Zynga (ZNGA) upgraded to Overweight from Equal Weight at Stephens with analyst Jeff Cohen saying the continued acceleration of recent acquisitions and the fact that Social Casino could be poised for a second half re-acceleration give him additional confidence in Zynga's live service portfolio. 4. Penumbra (PEN) upgraded to Overweight from Neutral at JPMorgan with analyst Robert Marcus saying the Street is overly focused on competitive entrants to the stroke aspiration market. 5. Cypress Semiconductor (CY) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Craig Hettenbach citing press reports indicating that the company is exploring strategic options. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/30/19
GUGG
05/30/19
UPGRADE
GUGG
Buy
Comcast upgraded to Buy from Neutral at Guggenheim
CMCSK Comcast
$0.00

(0.00%)

11/08/18
MSCO
11/08/18
INITIATION
Target $46
MSCO
Overweight
Comcast resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne resumed coverage of Comcast (CMCSA) with an Overweight rating and $46 price target, stating that while the burden of proof is on the company to successfully execute its Sky (SKYAY) acquisition, the stock's multiple has compressed even though his expectation for Comcast's consolidated growth outlook has not materially changed. In the near-term, Sky will be accretive to that growth rate, Swinburne added. He also said that Comcast "remains first and foremost a US cable business," and he sees broadband as a secular growth driver with a long-term runway.
12/07/18
WOLF
12/07/18
INITIATION
Target $48
WOLF
Outperform
Comcast Comcast initiated with an Outperform at Wolfe Research
Wolfe Research initiated Comcast with an Outperform rating and $48 price target.
02/11/19
KEYB
02/11/19
NO CHANGE
Target $216
KEYB
Overweight
Workday price target raised to $216 from $179 at KeyBanc
KeyBanc analyst Brent Bracelin raised his price target for Workday (WDAY) to $216 from $179 on improving cloud growth prospects. The analyst notes that analysis of Key First Look Data: Jobs has exposed an unannounced F50 HCM win at UPS (UPS) that began hiring for the global HR transformation team in January. The data also exposed unannounced F100 HCM wins at Comcast (CMCSA; CMCSK), CapitalOne (COF), and Centene (CNC), although job dates suggest these deals may have closed in the October quarter. The January data also exposed a new cloud financials win at Adecco (AHEXY), Bracelin adds. The analyst reiterates an Overweight rating on Workday's shares.
10/30/18
MSCO
10/30/18
NO CHANGE
Target $95
MSCO
Overweight
WWE shares 'on sale' after pullback, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne noted that WWE (WWE) shares are down by over 30% this month, which he sees as a "rare opportunity" to buy shares of a company that he sees having both highly visible earnings growth and growing intellectual property value. He attributes the rapid selloff primarily to a broader market rotation out of risk assets due to rising interest rates and concerns over achieving long-term growth, but he thinks this "does not make sense" given that WWE's EBITDA opportunity "is not a decade away, but rather a year away," Swinburne tells investors. Two contracts underwritten by Comcast (CMCSA) and Fox (FOXA) drive the bulk of its earnings growth and its financial outlook has no immediate exposure to ratings or cord-cutting, Swinburne added. While he trimmed his price target on WWE shares to $95 from $105 after bumping up his investment expectations for 2019, the analyst maintains an Overweight rating on the stock.
DISH Dish
$36.11

1.35 (3.88%)

05/06/19
05/06/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Sinclair Broadcast (SBGI) upgraded to Buy from Neutral at B. Riley FBR with analyst Barton Crockett saying yhe company's deal to acquire 21 regional sports networks from Disney (DIS) at valuation of $10.6B "looks like a home-run". 2. ImmunoGen (IMGN) upgraded to Buy from Neutral at H.C. Wainwright with analyst Debjit Chattopadhyay seeing 40% downside risk to the stock if the FDA does not consider mirvetuximab to be a clinically meaningful addition to the armametum against ovarian cancer versus a 145% upside potential. 3. Dish (DISH) upgraded to Neutral from Underperform at Credit Suisse with analyst Douglas Mitchelson saying he finds that risk/reward and potential catalysts across wireless and Pay TV are now in balance. 4. Post Holdings (POST) upgraded to Buy from Neutral at Goldman Sachs with analyst Jason English stating he views the recent pullback as a buying opportunity as he thinks transient headwinds were the reason results missed investor expectations in Q2. 5. Dentsply Sirona (XRAY) upgraded to Outperform from Market Perform at Barrington with analyst Michael Petusky saying the company's turnaround is "now on a firm, provable footing". This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/06/19
05/06/19
UPGRADE
Target $34

Neutral
Dish upgraded to Neutral at Credit Suisse on improving video subscriptions
As previously reported, Credit Suisse analyst Douglas Mitchelson upgraded Dish to Neutral from Underperform saying he finds that risk/reward and potential catalysts across wireless and Pay TV are now in balance. In particular, the analyst believes "video subscriber losses are at a nadir and likely to improve dramatically" in the second half of the year as programming dispute impacts expire, while the remaining subscriber base is longer-tenured, more rural, and thus lower churn. While pay TV financial results will likely be pressured all year, this pressure was already evident in Q1 results and improving subscriber losses will be considered a leading indicator, Mitchelson adds. He also raised his price target on the shares to $34 from $26.
05/20/19
PIVT
05/20/19
DOWNGRADE
PIVT
Hold
Dish downgraded to Hold from Buy at Pivotal Research
05/20/19
05/20/19
DOWNGRADE

Hold
Dish downgraded to Hold at Pivotal Research
As previously reported, Pivotal Research analyst Jeffrey Wlodarczak downgraded Dish (DISH) to Hold from Buy as it appears that the Sprint (S)/T-Mobile (TMUS) deal will clear regulatory hurdles and given the 22.9M share equity deal with sister company EchoStar (SATS). The likely ultimate approval of the Sprint/T-Mobile deal likely "significantly pushes back the timing" for a potential Dish spectrum deal materially, he contends.

TODAY'S FREE FLY STORIES

XLNX

Xilinx

$96.18

3.4 (3.66%)

, INTC

Intel

$52.06

0.95 (1.86%)

20:45
10/13/19
10/13
20:45
10/13/19
20:45
Upgrade
Xilinx, Intel rating change at Nomura Instinet »

Xilinx upgraded to Buy…

XLNX

Xilinx

$96.18

3.4 (3.66%)

INTC

Intel

$52.06

0.95 (1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 20

    Nov

SFTBY

SoftBank

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

19:49
10/13/19
10/13
19:49
10/13/19
19:49
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

SFTBY

SoftBank

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

FB

Facebook

$184.20

4.02 (2.23%)

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

TGT

Target

$111.86

1.29 (1.17%)

T

AT&T

$37.58

0.17 (0.45%)

ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

NUE

Nucor

$52.69

2.48 (4.94%)

PNR

Pentair

$37.33

1.215 (3.36%)

GWW

Grainger

$305.24

16.49 (5.71%)

K

Kellogg

$62.14

-0.27 (-0.43%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

TTWO

Take-Two

$122.42

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 18

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

IGMS

IGM Biosciences

$17.53

-0.125 (-0.71%)

19:42
10/13/19
10/13
19:42
10/13/19
19:42
Initiation
IGM Biosciences initiated at Piper Jaffray »

IGM Biosciences initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMAT

LeMaitre

$31.29

-0.03 (-0.10%)

19:37
10/13/19
10/13
19:37
10/13/19
19:37
Hot Stocks
LeMaitre acquires biologic patch business from Admedus »

LeMaitre Vascular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

WE

We Company

$0.00

(0.00%)

, SFTBF

SoftBank

$0.00

(0.00%)

18:37
10/13/19
10/13
18:37
10/13/19
18:37
Periodicals
SoftBank seeking control of WeWork through financing package, WSJ says »

SoftBank (SFTBY) has…

WE

We Company

$0.00

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KOD

Kodiak Sciences

$18.24

1.34 (7.93%)

18:34
10/13/19
10/13
18:34
10/13/19
18:34
Hot Stocks
Kodiak Sciences announces safety, efficacy from Phase 1b study of KSI-301 »

Kodiak Sciences announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

18:29
10/13/19
10/13
18:29
10/13/19
18:29
Recommendations
Adverum Biotechnologies analyst commentary at Piper Jaffray »

Adverum '022 looking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADVM

Adverum Biotechnologies

$5.29

0.11 (2.12%)

18:23
10/13/19
10/13
18:23
10/13/19
18:23
Hot Stocks
Adverum Biotechnologies reports additional data from Phase 1 trial of ADVM-022 »

Adverum Biotechnologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COP

ConocoPhillips

$56.41

0.55 (0.98%)

18:03
10/13/19
10/13
18:03
10/13/19
18:03
Hot Stocks
ConocoPhillips announces $1.39B agreement to sell interests in Australia-West »

ConocoPhillips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

T

AT&T

$37.58

0.17 (0.45%)

, CMCSA

Comcast

$45.53

1.02 (2.29%)

17:18
10/13/19
10/13
17:18
10/13/19
17:18
On The Fly
Box Office Battle: 'Joker' stays at number 1 with another $55M »

"Box Office Battle" is…

T

AT&T

$37.58

0.17 (0.45%)

CMCSA

Comcast

$45.53

1.02 (2.29%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$58.16

0.83 (1.45%)

LGF.A

Lionsgate

$9.52

0.22 (2.37%)

LGF.B

Lionsgate

$8.97

0.19 (2.16%)

DIS

Disney

$130.08

0.73 (0.56%)

VIAB

Viacom

$23.02

0.505 (2.24%)

VIA

Viacom

$25.45

0.65 (2.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 27

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

PCG

PG&E

$8.08

0.3 (3.86%)

16:48
10/13/19
10/13
16:48
10/13/19
16:48
Periodicals
PG&E turns down San Francisco's $2.5B offer to acquire assets, Reuters says »

PG&E rejected a $2.5B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

TTGT

TechTarget

$22.64

0.14 (0.62%)

, SKHCY

Sonic Healthcare

$0.00

(0.00%)

16:44
10/13/19
10/13
16:44
10/13/19
16:44
Conference/Events
Commvault to hold a conference »

Commvault GO 2019 will be…

TTGT

TechTarget

$22.64

0.14 (0.62%)

SKHCY

Sonic Healthcare

$0.00

(0.00%)

NTAP

NetApp

$51.50

1.74 (3.50%)

HPE

HP Enterprise

$14.35

0.24 (1.70%)

HLF

Herbalife Nutrition

$39.07

0.51 (1.32%)

FORR

Forrester

$32.43

0.61 (1.92%)

CSCO

Cisco

$46.52

0.38 (0.82%)

CVLT

Commvault

$45.51

0.695 (1.55%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Oct

  • 23

    Oct

  • 29

    Oct

  • 29

    Oct

  • 06

    Nov

  • 12

    Nov

  • 13

    Nov

  • 12

    Dec

FB

Facebook

$184.20

4.02 (2.23%)

16:43
10/13/19
10/13
16:43
10/13/19
16:43
Periodicals
Warren buying Facebook ads claiming Zuckerberg backs Trump, Bloomberg says »

Elizabeth Warren is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 30

    Oct

KBH

KB Home

$33.92

-0.15 (-0.44%)

16:43
10/13/19
10/13
16:43
10/13/19
16:43
Conference/Events
SunTrust to hold a field trip »

Field Trip with KB Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Oct

BX

Blackstone

$47.10

0.62 (1.33%)

16:34
10/13/19
10/13
16:34
10/13/19
16:34
Periodicals
Blackstone discussed with Citadel about buying stake, WSJ reports »

Blackstone has held talks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

16:29
10/13/19
10/13
16:29
10/13/19
16:29
Periodicals
Google bars high-interest consumer loan services from app store, WSJ reports »

Google has barred…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

16:28
10/13/19
10/13
16:28
10/13/19
16:28
General news
Trump working with Congress on 'powerful' Turkey sanctions »

President Trump tweeted…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$169.06

1.255 (0.75%)

16:23
10/13/19
10/13
16:23
10/13/19
16:23
Hot Stocks
Allergan, Molecular Partners present data from Phase 3 Abicipar pegol studies »

Allergan and Molecular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$39.49

1.8 (4.78%)

, UBER

Uber

$30.09

1.19 (4.12%)

16:04
10/13/19
10/13
16:04
10/13/19
16:04
Periodicals
Lyft sues NYC over cruising time caps, Reuters reports »

Following its rival…

LYFT

Lyft

$39.49

1.8 (4.78%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 04

    Nov

  • 07

    Nov

  • 19

    Nov

GM

General Motors

$35.57

0.9 (2.60%)

15:59
10/13/19
10/13
15:59
10/13/19
15:59
Periodicals
UAW boosting strike pay as General Motor walkout continues, Reuters says »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$84.31

0.6 (0.72%)

, JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

15:49
10/13/19
10/13
15:49
10/13/19
15:49
Periodicals
Congo to start using Johnson & Johnson Ebola vaccine next month, Reuters says »

Health authorities in…

MRK

Merck

$84.31

0.6 (0.72%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HMTV

Hemisphere Media

$11.70

0.05 (0.43%)

15:48
10/13/19
10/13
15:48
10/13/19
15:48
Initiation
Hemisphere Media initiated at Wells Fargo »

Hemisphere Media…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.11

0.31 (0.87%)

15:37
10/13/19
10/13
15:37
10/13/19
15:37
Hot Stocks
Pfizer presents Phase 3 data for Abrocitinib in moderate to severe AD »

Pfizer announced complete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

CNCE

Concert Pharmaceuticals

$5.85

(0.00%)

15:29
10/13/19
10/13
15:29
10/13/19
15:29
Hot Stocks
Concert Pharmaceuticals presents Phase 2 data in Alopecia Areata »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$76.14

0.38 (0.50%)

15:23
10/13/19
10/13
15:23
10/13/19
15:23
Hot Stocks
Incyte announces 52-week results from Phase 2 study of Ruxolitinib cream »

Incyte announced 52-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.